I happened across the below PR portion and it struck me that CYDY may be going thru this stage right now. CYDY has no CEO, new BOD members, new management team, no approvals, and financing problems. Makes us ripe for a lowball offer that the BOD could be considering. I don't have any TLMD, but I have went thru this with two previous biotech stocks in which the shareholders were sandbagged with what the BOD accepted vs what the shareholders thought was a reasonable price. TLMD was at $.59 and was bought out for $3.
Hoping I'm full of #@#& on this but it just struck me on what our new management team and BOD members might really be thinking.

Telemed (TLMD) PR pertaining to buyout offer:
"After being approached by Patient Square Capital, we formed an independent committee of the Board, which thoroughly reviewed the proposal with the assistance of independent financial and legal advisors. Following the independent committee's unanimous recommendation, the Board unanimously determined that the all-cash offer unlocks maximum value to stockholders, and that the experience and resources of Patient Square Capital would best position the Company for growth in the years to come."